Cargando…
Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells
Langerhans cells (LCs) are the antigen-presenting cells of the epithelial layer and are responsible for initiating immune responses against skin and mucosa-invading viruses. Human papillomavirus (HPV)-mediated suppression of LC function is a crucial mechanism of HPV immune evasion, which can lead to...
Autores principales: | Da Silva, Diane M., Woodham, Andrew W., Naylor, Paul H., Egan, James E., Berinstein, Neil L., Kast, W. Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854212/ https://www.ncbi.nlm.nih.gov/pubmed/26653678 http://dx.doi.org/10.1089/jir.2015.0115 |
Ejemplares similares
-
IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers
por: Wolf, Gregory T, et al.
Publicado: (2018) -
Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C
por: Da Silva, Diane M., et al.
Publicado: (2015) -
Peptide Based Vaccine Approaches for Cancer—A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory Regimen
por: Naylor, Paul H., et al.
Publicado: (2011) -
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation
por: Woodham, Andrew W., et al.
Publicado: (2016) -
Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen
por: Berinstein, Neil L., et al.
Publicado: (2018)